JP2008506710A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008506710A5 JP2008506710A5 JP2007521685A JP2007521685A JP2008506710A5 JP 2008506710 A5 JP2008506710 A5 JP 2008506710A5 JP 2007521685 A JP2007521685 A JP 2007521685A JP 2007521685 A JP2007521685 A JP 2007521685A JP 2008506710 A5 JP2008506710 A5 JP 2008506710A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- aralkyl
- pharmaceutical composition
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 29
- 125000000217 alkyl group Chemical group 0.000 claims 22
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 125000003710 aryl alkyl group Chemical group 0.000 claims 9
- 125000003118 aryl group Chemical group 0.000 claims 9
- 206010028980 Neoplasm Diseases 0.000 claims 8
- 201000011510 cancer Diseases 0.000 claims 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims 6
- 229910052799 carbon Inorganic materials 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 2
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 230000008018 melting Effects 0.000 claims 2
- 238000002844 melting Methods 0.000 claims 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 claims 2
- 229910052711 selenium Inorganic materials 0.000 claims 2
- SHGAZHPCJJPHSC-ZVCIMWCZSA-N 9-cis-retinoic acid Chemical compound OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-ZVCIMWCZSA-N 0.000 claims 1
- 208000036762 Acute promyelocytic leukaemia Diseases 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 claims 1
- 208000014767 Myeloproliferative disease Diseases 0.000 claims 1
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 208000033826 Promyelocytic Acute Leukemia Diseases 0.000 claims 1
- 208000009527 Refractory anemia Diseases 0.000 claims 1
- 206010072684 Refractory cytopenia with unilineage dysplasia Diseases 0.000 claims 1
- 229960001445 alitretinoin Drugs 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 210000000601 blood cell Anatomy 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 201000006491 bone marrow cancer Diseases 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 210000001072 colon Anatomy 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 210000004696 endometrium Anatomy 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 210000003128 head Anatomy 0.000 claims 1
- 230000002489 hematologic effect Effects 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 210000001165 lymph node Anatomy 0.000 claims 1
- -1 methyl compound Chemical class 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 210000003739 neck Anatomy 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 210000000496 pancreas Anatomy 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 229930002330 retinoic acid Natural products 0.000 claims 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N retinoic acid group Chemical group C\C(=C/C(=O)O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 210000000813 small intestine Anatomy 0.000 claims 1
- 210000000952 spleen Anatomy 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 claims 1
- MUTNCGKQJGXKEM-UHFFFAOYSA-N tamibarotene Chemical compound C=1C=C2C(C)(C)CCC(C)(C)C2=CC=1NC(=O)C1=CC=C(C(O)=O)C=C1 MUTNCGKQJGXKEM-UHFFFAOYSA-N 0.000 claims 1
- 210000001550 testis Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58859604P | 2004-07-16 | 2004-07-16 | |
| US60/588,596 | 2004-07-16 | ||
| PCT/US2005/025192 WO2006020048A2 (en) | 2004-07-16 | 2005-07-15 | Compounds and methods for treatment of cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011227543A Division JP2012051919A (ja) | 2004-07-16 | 2011-10-17 | 癌の治療のための化合物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008506710A JP2008506710A (ja) | 2008-03-06 |
| JP2008506710A5 true JP2008506710A5 (enExample) | 2008-07-31 |
| JP5618461B2 JP5618461B2 (ja) | 2014-11-05 |
Family
ID=35414967
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007521685A Expired - Fee Related JP5618461B2 (ja) | 2004-07-16 | 2005-07-15 | 癌の治療のための化合物および方法 |
| JP2011227543A Withdrawn JP2012051919A (ja) | 2004-07-16 | 2011-10-17 | 癌の治療のための化合物および方法 |
| JP2014037807A Expired - Lifetime JP5745660B2 (ja) | 2004-07-16 | 2014-02-28 | 癌の治療のための化合物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011227543A Withdrawn JP2012051919A (ja) | 2004-07-16 | 2011-10-17 | 癌の治療のための化合物および方法 |
| JP2014037807A Expired - Lifetime JP5745660B2 (ja) | 2004-07-16 | 2014-02-28 | 癌の治療のための化合物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7405314B2 (enExample) |
| EP (1) | EP1771459A2 (enExample) |
| JP (3) | JP5618461B2 (enExample) |
| KR (5) | KR101252866B1 (enExample) |
| CN (3) | CN104163833A (enExample) |
| AU (1) | AU2005274926B2 (enExample) |
| CA (2) | CA2574032C (enExample) |
| HK (1) | HK1204476A1 (enExample) |
| IL (2) | IL180729A (enExample) |
| TW (3) | TW201440760A (enExample) |
| WO (1) | WO2006020048A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2420229A1 (en) | 2002-01-07 | 2012-02-22 | Board Of Regents, University Of Texas System | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| US7628810B2 (en) | 2003-05-28 | 2009-12-08 | Acufocus, Inc. | Mask configured to maintain nutrient transport without producing visible diffraction patterns |
| TW201440760A (zh) | 2004-07-16 | 2014-11-01 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
| EP1919564B1 (en) | 2005-07-29 | 2014-11-26 | Ziopharm Oncology, Inc. | Compounds and methods for the treatment of cancer |
| CN104109177A (zh) * | 2006-01-13 | 2014-10-22 | 得克萨斯州A&M大学系统 | 用于治疗癌症的化合物和方法 |
| RU2318519C2 (ru) * | 2006-03-06 | 2008-03-10 | ФГУ Ростовский научно-исследовательский онкологический институт Росздрава | Способ химиотерапии острого лейкоза |
| TW200829261A (en) * | 2006-09-29 | 2008-07-16 | Ziopharm Oncology Inc | Method for controlling angiogenesis in animals |
| JP2011502985A (ja) | 2007-11-02 | 2011-01-27 | ジオファーム オンコロジー， インコーポレイテッド | 有機ヒ素剤を使用する併用療法 |
| US20100331403A1 (en) * | 2007-12-12 | 2010-12-30 | Amedio Jr John C | Compounds and methods for the treatment of cancer |
| SG10201810449XA (en) * | 2008-08-20 | 2018-12-28 | Solasia Pharma K K | Organoarsenic compounds and methods for the treatment of cancer |
| CN102060722B (zh) * | 2009-05-01 | 2014-06-11 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种含砷化合物及其制备方法和用途 |
| US10004593B2 (en) | 2009-08-13 | 2018-06-26 | Acufocus, Inc. | Intraocular lens with elastic mask |
| CA2770735C (en) | 2009-08-13 | 2017-07-18 | Acufocus, Inc. | Masked intraocular implants and lenses |
| WO2012170384A1 (en) | 2011-06-06 | 2012-12-13 | Chevron Phillips Chemical Company Lp | Use of metallocene compounds for cancer treatment |
| WO2013082545A1 (en) | 2011-12-02 | 2013-06-06 | Acufocus, Inc. | Ocular mask having selective spectral transmission |
| US9427922B2 (en) | 2013-03-14 | 2016-08-30 | Acufocus, Inc. | Process for manufacturing an intraocular lens with an embedded mask |
| WO2015085208A1 (en) * | 2013-12-05 | 2015-06-11 | Solasia Pharma K.K. | Compounds and methods for the treatment of cancer |
| GB201418491D0 (en) * | 2014-10-17 | 2014-12-03 | Monfort University De | Compounds |
| US9943403B2 (en) | 2014-11-19 | 2018-04-17 | Acufocus, Inc. | Fracturable mask for treating presbyopia |
| EP3359987B1 (en) | 2015-10-05 | 2024-02-28 | AcuFocus, Inc. | Methods of molding intraocular lenses |
| CN108431676B (zh) | 2015-11-24 | 2022-01-04 | 阿库福库斯公司 | 具有延伸的焦深的复曲面小孔口人工晶状体 |
| CN105330701B (zh) * | 2015-11-27 | 2017-05-31 | 昆明医科大学 | 一种含砷化合物及其制备方法和应用 |
| EP3790508A4 (en) | 2018-05-09 | 2022-02-09 | AcuFocus, Inc. | INTRAOCULAR IMPLANT WITH REMOVABLE OPTICS |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1391206T3 (da) | 1997-10-15 | 2008-09-01 | Polarx Biopharmaceuticals Inc | Farmaceutiske præparater der omfatter arsentrioxyd til behandling af ikke-Hodgkins lymfom |
| CA2309652C (en) | 1997-11-10 | 2013-01-29 | Memorial Sloan-Kettering Cancer Center | Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| CN1233476A (zh) | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
| EP1002537A1 (en) | 1998-10-30 | 2000-05-24 | Assistance Publique, Hopitaux De Paris | Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma |
| US6191123B1 (en) | 1999-03-19 | 2001-02-20 | Parker Hughes Institute | Organic-arsenic compounds |
| WO2001080832A2 (en) | 2000-04-26 | 2001-11-01 | Oregon Health Sciences University | Administration of a thiol-based chemoprotectant compound |
| EP2420229A1 (en) * | 2002-01-07 | 2012-02-22 | Board Of Regents, University Of Texas System | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| TW201440760A (zh) | 2004-07-16 | 2014-11-01 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
-
2005
- 2005-07-14 TW TW103121164A patent/TW201440760A/zh unknown
- 2005-07-14 TW TW094123873A patent/TWI411431B/zh not_active IP Right Cessation
- 2005-07-14 TW TW102125370A patent/TW201350113A/zh unknown
- 2005-07-15 AU AU2005274926A patent/AU2005274926B2/en not_active Ceased
- 2005-07-15 KR KR1020077003723A patent/KR101252866B1/ko not_active Expired - Fee Related
- 2005-07-15 WO PCT/US2005/025192 patent/WO2006020048A2/en not_active Ceased
- 2005-07-15 KR KR1020137021239A patent/KR20130095857A/ko not_active Ceased
- 2005-07-15 CA CA2574032A patent/CA2574032C/en not_active Expired - Fee Related
- 2005-07-15 EP EP05790733A patent/EP1771459A2/en not_active Withdrawn
- 2005-07-15 KR KR1020147030246A patent/KR20140136525A/ko not_active Ceased
- 2005-07-15 CN CN201310451346.9A patent/CN104163833A/zh active Pending
- 2005-07-15 CN CN201610256017.2A patent/CN105777811A/zh active Pending
- 2005-07-15 CN CN2005800303713A patent/CN101076533B/zh not_active Expired - Fee Related
- 2005-07-15 KR KR1020127030429A patent/KR20130001323A/ko not_active Ceased
- 2005-07-15 CA CA2777473A patent/CA2777473C/en not_active Expired - Fee Related
- 2005-07-15 KR KR1020147000020A patent/KR20140013110A/ko not_active Withdrawn
- 2005-07-15 JP JP2007521685A patent/JP5618461B2/ja not_active Expired - Fee Related
- 2005-10-17 US US11/252,966 patent/US7405314B2/en not_active Expired - Lifetime
-
2007
- 2007-01-16 IL IL180729A patent/IL180729A/en not_active IP Right Cessation
- 2007-08-20 US US11/894,766 patent/US20080090793A1/en not_active Abandoned
-
2011
- 2011-10-17 JP JP2011227543A patent/JP2012051919A/ja not_active Withdrawn
- 2011-10-25 IL IL215896A patent/IL215896A0/en unknown
-
2014
- 2014-02-28 JP JP2014037807A patent/JP5745660B2/ja not_active Expired - Lifetime
-
2015
- 2015-05-26 HK HK15104992.3A patent/HK1204476A1/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008506710A5 (enExample) | ||
| CA2574032A1 (en) | Compounds and methods for the treatment of cancer | |
| JP4959900B2 (ja) | 抗ウイルスピリミジンヌクレオシド類 | |
| JP7121660B2 (ja) | 癌を処置するためのｅｚｈ２阻害剤の使用 | |
| ES2895749T3 (es) | Métodos de tratamiento del cáncer pancreático | |
| CA2619828A1 (en) | Methods to enhance chemotherapy | |
| CN107105660A (zh) | 使用替唑尼特、其类似物或盐的前药的治疗组合物和治疗方法 | |
| JP2022501344A (ja) | 新規キナゾリンｅｇｆｒ阻害剤 | |
| US20170157131A1 (en) | Antitumor effect potentiator and antitumor agent | |
| JP2017532316A5 (enExample) | ||
| CZ166893A3 (en) | Pharmaceutical composition | |
| JP2005531563A5 (enExample) | ||
| CA2410160C (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents | |
| JP2016501884A5 (enExample) | ||
| US20080293648A1 (en) | Compositions and Methods for Cancer Treatment | |
| ES2317913T3 (es) | Tratamiento antitumoral combinado que comprende un derivado de la distamicina sustituida por acriloilo y un antimetabolito. | |
| JP2010500971A5 (enExample) | ||
| JP2009527463A5 (enExample) | ||
| CA2427569A1 (en) | Selective glucocorticoid receptor agonists | |
| JP2011502985A5 (enExample) | ||
| JP2013227347A5 (enExample) | ||
| WO2013137433A1 (ja) | ３剤を組み合わせた新規な抗腫瘍剤 | |
| PT1757283E (pt) | Potenciador do efeito antitumoral, agente antitumoral e método para a terapia do cancro | |
| JP2003535874A5 (enExample) | ||
| US20050101534A1 (en) | Compositions and methods for treating or preventing hearing impairment |